Cancer Institute A national cancer institute
designated cancer center

Sean Mackey, M.D., Ph.D.

Publication Details

  • Pain quality predicts lidocaine analgesia among patients with suspected neuropathic pain.

    Carroll IR, Younger JW, Mackey SC. Pain Med. 2010; 11 (4): 617-21

    Oral sodium channel blockers have shown mixed results in randomized controlled trials despite the known importance of sodium channels in generating pain. We hypothesized that differing baseline pain qualities (e.g. "stabbing" vs "dull") might define specific subgroups responsive to intravenous (IV) lidocaine-a potent sodium channel blocker.

    PubMedID: 20210867

Stanford Medicine Resources:

Footer Links: